TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2025-03-04
余忠仁Yu, Chong-Jen
- 計畫主持人
- 執行臨床試驗年資 23 年 9 個月
發表文獻
116筆
71
Chang HC, Hsu CL, Chang YL, Yu CJ. Pulmonary pleomorphic carcinoma with pembrolizumab monotherapy. Respirol Case Rep. 2020 Jun 12;8(6):e0597. doi: 10.1002/rcr2.597. PMID: 32547767; PMCID: PMC7290282.
72
Yang WC, Hsu FM, Chen YH, Shih JY, Yu CJ, Lin ZZ, Lu SH, Yang JC, Cheng AL, Kuo SH. Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer. Clin Transl Radiat Oncol. 2020 Mar 23;22:76-82. doi: 10.1016/j.ctro.2020.03.008. PMID: 32280792; PMCID: PMC7139144.
73
Wu SG, Yu CJ, Yang JC, Shih JY. The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation. Ther Adv Med Oncol. 2020 Aug 10;12:1758835920946156. doi: 10.1177/1758835920946156. PMID: 32843903; PMCID: PMC7418472.
74
Lin YT, Tsai TH, Wu SG, Liu YN, Yu CJ, Shih JY. Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer. Lung Cancer. 2020 Jul;145:1-9. doi: 10.1016/j.lungcan.2020.04.022. Epub 2020 Apr 30. PMID: 32387812.
75
Huang CT, Ruan SY, Tsai YJ, Ku SC, Yu CJ. Clinical Trajectories and Causes of Death in Septic Patients with a Low APACHE II Score. J Clin Med. 2019 Jul 20;8(7):1064. doi: 10.3390/jcm8071064. PMID: 31330785; PMCID: PMC6678558.
76
Hsiue EH, Lee PL, Chen YH, Wu TH, Cheng CF, Cheng KM, Yang PC, Chen HW, Lin PY, Chiang DL, Wu HD, Yang JC, Yu CJ. Weaning outcome of solid cancer patients requiring mechanical ventilation in the intensive care unit. J Formos Med Assoc. 2019 Jun;118(6):995-1004. doi: 10.1016/j.jfma.2019.02.007. Epub 2019 Mar 8. PMID: 30857753.
77
Shu CC, Pan SW, Feng JY, Wang JY, Chan YJ, Yu CJ, Su WJ. The Clinical Significance of Programmed Death-1, Regulatory T Cells and Myeloid Derived Suppressor Cells in Patients with Nontuberculous Mycobacteria-Lung Disease. J Clin Med. 2019 May 23;8(5):736. doi: 10.3390/jcm8050736. PMID: 31126067; PMCID: PMC6572058.
78
Chung KP, Hsu CL, Fan LC, Huang Z, Bhatia D, Chen YJ, Hisata S, Cho SJ, Nakahira K, Imamura M, Choi ME, Yu CJ, Cloonan SM, Choi AMK. Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis. Nat Commun. 2019 Jul 29;10(1):3390. doi: 10.1038/s41467-019-11327-1. PMID: 31358769; PMCID: PMC6662701.
79
Yang CY, Hsieh MS, Liao WY, Shih JY, Yu CJ. Consecutive Emergence of Typical Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in a Patient With Metastatic Pulmonary Squamous Cell Carcinoma. J Oncol Pract. 2019 Feb;15(2):115-118. doi: 10.1200/JOP.18.00536. PMID: 30763203.
80
Wu SG, Chang TH, Tsai MF, Liu YN, Hsu CL, Chang YL, Yu CJ, Shih JY. IGFBP7 Drives Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition in Lung Cancer. Cancers (Basel). 2019 Jan 2;11(1):36. doi: 10.3390/cancers11010036. PMID: 30609749; PMCID: PMC6356910.
